Reports of COVID Vaccine “Shedding” Raise New Questions
For years, individuals have reported unusual symptoms after close contact with people who recently received a COVID shot.
A detailed analysis published by the Substack author A Midwestern Doctor examines these reports and what emerging evidence may suggest about the possibility of post-injection “shedding.”
In this context, shedding refers to the idea that biological materials produced after an mRNA COVID injection — such as spike protein or related byproducts — could potentially be transferred from an injected person to others through close contact.
After inviting readers and clinicians to share their experiences, the author reports compiling roughly 1,500 accounts of suspected shedding, which were analyzed to identify recurring symptom patterns and exposure scenarios.
According to the article, physicians, researchers and members of the public have reported patterns of symptoms in some individuals who were not injected but spent time near those who recently received a COVID shot.
Among the symptoms most frequently reported:
• menstrual cycle disruptions
• unusual bleeding
• fatigue or neurological symptoms
• skin reactions
• hormonal changes
The article also notes that some people report detecting a distinct or unusual odor around recently injected individuals, particularly shortly after the injection. In some accounts, the smell has been described as chemical-like or metallic, though the source of the odor remains unclear.
Some reports describe symptoms appearing within hours or days of close contact, while others suggest that only a subset of individuals appear particularly sensitive, with many people experiencing no noticeable effects.
The analysis also explores possible biological mechanisms that could explain these observations, including the potential transmission of spike protein fragments or other biological particles produced after injection. However, the precise biological pathway has not yet been confirmed, and the topic remains controversial.
One challenge highlighted by the author is the lack of formal research examining whether shedding could occur with mRNA products. Because the COVID shots were rolled out rapidly, the article argues that certain questions — including possible secondary exposure effects — were not thoroughly studied before mass deployment.
Although the article does not provide a geographic breakdown of the roughly 1,500 reports, similar concerns have been raised by individuals in Canada who say they experienced unusual symptoms after close contact with someone who had recently received a COVID shot.
Because the article examines numerous reports, observations and hypotheses in detail, readers are encouraged to review the full analysis to better understand the evidence and arguments presented.
Read the full article HERE.
********************************************************************************************************************************